MicrobiologybioRxiv
Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro
M. H. Raymonda, J. H. Ciesla, M. Monaghan…·I. S. Harris
This study identifies lapatinib as a potent antiviral against SARS-CoV-2 in vitro, showing over 50,000-fold inhibition without toxicity.
DOI 10.1016/j.virol.2021.11.008